ARVN FY 2018 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+89.0% YoY

Gross Profit

$14M100.0% margin

Operating Income

-$44M-305.8% margin

Net Income

-$41M-289.6% margin

EPS (Diluted)

$-1.31

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$19M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$199M

Total Liabilities

$63M

Stockholders' Equity

$137M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$8M	+89.0%
Gross Profit	$14M	$8M	+89.0%
Operating Income	-$44M	-$25M	-76.9%
Net Income	-$41M	-$24M	-72.5%